Jumlah Saham Beredar | 43,750,086 shares |
Saham Orang Dalam | 35,531,914 shares |
Kepemilikan oleh Orang Dalam | 81.22 % |
Orang Dalam Sejati | 21 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
1596 out of 11305Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
1589 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Prelude Therapeutics Incorporated transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Baker Bros. Advisors Lp
Director, 10% Owner -
[D]
|
9,252,951 | 9,252,951 | |
Julian Baker
Director, 10% Owner -
[D]
|
9,252,951 | 9,252,951 | |
Martin Babler | 36,400 | ||
David P Bonita
Director, 10% Owner -
[D]
|
10,646,056 | 10,646,056 | |
Laurent Chardonnet Chief Financial Officer - [O] | 42,165 | 42,165 | |
Andrew Combs Chief Chemistry Officer - [O] | 480,123 | 480,123 | |
Mardi Dier Director - [D] | 10,000 | 10,000 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Paul A Friedman Director - [D] | 500,098 | 500,098 | |
Jane Huang President, CMO - [O] | 80,897 | 80,897 | |
Bryant David Lim CLO, Interim CFO, Corp Sec. - [O] | 27,400 | 27,400 | |
David J Mauro Chief Medical Officer - [O] | 0 | 0 | |
Deborah Morosini EVP, Chief of Clinical Affairs - [O] | 444 | 444 | |
Kelvin Neu | 0 | ||
Orbimed Advisors Llc
Director, 10% Owner -
[D]
|
10,646,056 | 10,646,056 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Orbimed Capital Llc
Director, 10% Owner -
[D]
|
5,596,886 | 10,646,056 | |
OrbiMed Capital GP VI LLC
Director, 10% Owner -
[D]
|
5,596,886 | 10,646,056 | |
Christopher Pierce EVP and Chief of Business Oper - [O] | 3,750 | 3,750 | |
Brian Piper Chief Financial Officer - [O] | 0 | 0 | |
Victor Sandor | 11,206 | ||
Peggy Scherle Chief Scientific Officer - [O] | 172,920 | 172,920 | |
Krishna Vaddi CEO, Director - [D] [O] | 3,669,054 | 3,669,054 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di PRLD / Prelude Therapeutics Incorporated. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di PRLD / Prelude Therapeutics Incorporated. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Tanggal Perdagangan | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
---|---|---|---|---|---|---|---|---|---|---|
2023-04-06 | Huang Jane | 13,280 | 6.1200 | 13,280 | 6.1200 | 81,274 | 208 | 1.6900 | -58,830 | -72.39 |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-08 | 2025-07-04 | 4 | Huang Jane | PRLD | Common Stock | D | 0.7939 | -3,355 | -3 | 80,897 | ||||
2025-07-08 | 2025-07-04 | 4 | Huang Jane | PRLD | Common Stock | D | 9,375 | 84,252 | ||||||
2025-04-07 | 2025-04-04 | 4 | Huang Jane | PRLD | Common Stock | D | 0.6750 | -3,355 | -2 | 74,877 | ||||
2025-04-07 | 2025-04-04 | 4 | Huang Jane | PRLD | Common Stock | D | 9,375 | 78,232 | ||||||
2025-03-27 | 2025-03-25 | 4 | Combs Andrew | PRLD | Common Stock | D | 0.6925 | 100,000 | 69 | 480,123 | ||||
2025-03-27 | 2025-03-25 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 0.6925 | 675,000 | 467 | 1,999,296 | ||||
2025-03-24 | 2025-03-21 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 0.7306 | 15,000 | 11 | 1,324,296 | ||||
2025-03-24 | 2025-03-20 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 0.7294 | 5,416 | 4 | 1,309,296 | ||||
2025-03-18 | 2025-03-17 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 0.7499 | 9,106 | 7 | 1,303,880 | ||||
2025-03-18 | 2025-03-14 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 0.7544 | 29,999 | 23 | 1,294,774 | ||||
2025-03-14 | 2025-03-13 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 0.7164 | 50,000 | 36 | 1,264,775 | ||||
2025-03-14 | 2025-03-12 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 0.7104 | 47,500 | 34 | 1,214,775 | ||||
2025-01-07 | 2025-01-04 | 4 | Huang Jane | PRLD | Common Stock | D | 1.3900 | -3,859 | -5 | 68,857 | ||||
2025-01-07 | 2025-01-04 | 4 | Huang Jane | PRLD | Common Stock | D | 9,375 | 72,716 | ||||||
2025-01-03 | 2024-12-31 | 4 | Vaddi Krishna | PRLD | Common Stock | I | 1.2087 | 5,000 | 6 | 142,553 | ||||
2025-01-02 | 2024-12-30 | 4 | Vaddi Krishna | PRLD | Common Stock | I | 1.2000 | 10,000 | 12 | 137,553 | ||||
2024-12-26 | 2024-12-23 | 4 | Combs Andrew | PRLD | Common Stock | D | 1.3667 | 60,000 | 82 | 377,623 | ||||
2024-12-26 | 2024-12-20 | 4 | Combs Andrew | PRLD | Common Stock | D | 1.1500 | 3,075 | 4 | 317,623 | ||||
2024-12-20 | 2024-12-19 | 4 | Lim Bryant David | PRLD | Common Stock | D | 0.9055 | 25,000 | 23 | 27,400 | ||||
2024-12-20 | 2024-12-19 | 4 | Vaddi Krishna | PRLD | Common Stock | I | 0.8879 | 6,888 | 6 | 127,553 | ||||
2024-12-20 | 2024-12-18 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 0.9321 | 100,000 | 93 | 1,167,275 | ||||
2024-10-07 | 2024-10-04 | 4 | Huang Jane | PRLD | Common Stock | D | 2.0000 | -3,349 | -7 | 63,341 | ||||
2024-10-07 | 2024-10-04 | 4 | Huang Jane | PRLD | Common Stock | D | 9,375 | 66,690 | ||||||
2024-07-08 | 2024-07-04 | 4 | Huang Jane | PRLD | Common Stock | D | 3.6000 | -3,347 | -12 | 57,315 | ||||
2024-07-08 | 2024-07-04 | 4 | Huang Jane | PRLD | Common Stock | D | 9,375 | 60,662 | ||||||
2024-04-08 | 2024-04-04 | 4 | Huang Jane | PRLD | Common Stock | D | 4.7400 | -3,347 | -16 | 51,287 | ||||
2024-04-08 | 2024-04-04 | 4 | Huang Jane | PRLD | Common Stock | D | 9,375 | 54,634 | ||||||
2024-01-08 | 2024-01-04 | 4 | Huang Jane | PRLD | Common Stock | D | 3.7700 | -3,844 | -14 | 45,259 | ||||
2024-01-08 | 2024-01-04 | 4 | Huang Jane | PRLD | Common Stock | D | 9,375 | 49,103 | ||||||
2023-10-06 | 2023-10-04 | 4 | Huang Jane | PRLD | Common Stock | D | 9,375 | 39,728 | ||||||
2023-07-06 | 2023-07-04 | 4 | Huang Jane | PRLD | Common Stock | D | 4.6500 | -3,242 | -15 | 30,353 | ||||
2023-07-06 | 2023-07-04 | 4 | Huang Jane | PRLD | Common Stock | D | 9,375 | 33,595 | ||||||
2023-05-26 | 2023-05-25 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 5.3100 | 900 | 5 | 1,067,275 | ||||
2023-05-26 | 2023-05-24 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 5.0114 | 1,000 | 5 | 1,066,375 | ||||
2023-05-25 | 2023-05-23 | 4 | Chardonnet Laurent | PRLD | Common Stock | D | 5.5000 | 5,000 | 28 | 42,165 | ||||
2023-05-25 | 2023-05-24 | 4 | Lim Bryant David | PRLD | Common Stock | D | 5.3900 | 2,400 | 13 | 2,400 | ||||
2023-05-25 | 2023-05-23 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 5.6300 | 11,856 | 67 | 1,065,375 | ||||
2023-05-24 | 2023-05-22 | 4 | ORBIMED ADVISORS LLC See footnotes | PRLD | Common Stock | I | 5.7500 | 869,565 | 5,000 | 10,119,756 | ||||
2023-05-24 | 2023-05-22 | 4 | Bonita David P See footnotes | PRLD | Common Stock | I | 5.7500 | 869,565 | 5,000 | 10,119,756 | ||||
2023-04-06 | 2023-04-06 | 4 | Huang Jane | PRLD | Common Stock | D | 6.1200 | -13,280 | -81 | 24,220 | ||||
2023-04-06 | 2023-04-04 | 4 | Huang Jane | PRLD | Common Stock | D | 37,500 | 37,500 | ||||||
2022-12-21 | 2022-12-20 | 4 | Vaddi Krishna | PRLD | Common Stock | I | 5.1306 | 19,188 | 98 | 120,665 | ||||
2022-12-12 | 2022-12-08 | 4 | Chardonnet Laurent | PRLD | Common Stock | D | 4.7600 | 10,000 | 48 | 35,873 | ||||
2022-06-01 | 2022-06-01 | 4 | Chardonnet Laurent | PRLD | Common Stock | D | 4.2300 | 10,000 | 42 | 24,500 | ||||
2022-05-04 | 2022-05-02 | 4 | Huang Jane | PRLD | Restricted Stock Unit | D | 150,000 | 150,000 | ||||||
2022-05-04 | 2022-05-02 | 4 | Huang Jane | PRLD | Employee Stock Option (Right to Buy) | D | 4.86 | 460,000 | 460,000 | |||||
2022-04-04 | 2022-04-01 | 4 | Combs Andrew | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -36,062 | 50,397 | |||||
2022-04-04 | 2022-03-31 | 4 | Combs Andrew | PRLD | Common Stock | D | 1.8900 | 36,062 | 68 | 304,442 | ||||
2022-03-22 | 2022-03-21 | 4 | Chardonnet Laurent | PRLD | Common Stock | D | 7.5100 | 6,500 | 49 | 14,500 | ||||
2022-02-17 | 2022-02-15 | 4 | Chardonnet Laurent | PRLD | Employee Stock Option (right to buy) | D | 10.58 | 90,000 | 90,000 | |||||
2022-02-17 | 2022-02-15 | 4 | Scherle Peggy | PRLD | Employee Stock Option (right to buy) | D | 10.58 | 100,000 | 100,000 | |||||
2022-02-17 | 2022-02-15 | 4 | Morosini Deborah | PRLD | Employee Stock Option (right to buy) | D | 10.58 | 90,000 | 90,000 | |||||
2022-02-17 | 2022-02-15 | 4 | Vaddi Krishna | PRLD | Employee Stock Option (right to buy) | D | 10.58 | 327,900 | 327,900 | |||||
2022-02-17 | 2022-02-15 | 4 | Combs Andrew | PRLD | Employee Stock Option (right to buy) | D | 10.58 | 100,000 | 100,000 | |||||
2022-01-05 | 2022-01-03 | 4 | Sandor Victor | PRLD | Director Stock Option (Right to Buy) | D | 13.22 | 11,206 | 11,206 | |||||
2021-12-17 | 2021-12-15 | 4 | Morosini Deborah | PRLD | Employee Stock Option (right to buy) | D | 12.85 | -882 | 195,163 | |||||
2021-12-17 | 2021-12-15 | 4 | Morosini Deborah | PRLD | Employee Stock Option (right to buy) | D | 12.85 | -24,853 | 74,575 | |||||
2021-12-17 | 2021-12-15 | 4 | Morosini Deborah | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -3,016 | 1,307 | |||||
2021-12-17 | 2021-12-15 | 4 | Morosini Deborah | PRLD | Common Stock | D | 13.0000 | -28,751 | -374 | 444 | ||||
2021-12-17 | 2021-12-15 | 4 | Morosini Deborah | PRLD | Common Stock | D | 12.8500 | 25,735 | 331 | 29,195 | ||||
2021-12-17 | 2021-12-15 | 4 | Morosini Deborah | PRLD | Common Stock | D | 1.8900 | 3,016 | 6 | 3,460 | ||||
2021-12-15 | 2021-12-14 | 4 | Combs Andrew | PRLD | Common Stock | D | 11.6000 | 4,000 | 46 | 268,380 | ||||
2021-12-15 | 2021-12-13 | 4 | Combs Andrew | PRLD | Common Stock | D | 12.1200 | 4,000 | 48 | 264,380 | ||||
2021-12-14 | 2021-12-13 | 4 | Chardonnet Laurent | PRLD | Common Stock | D | 12.2800 | 5,000 | 61 | 8,000 | ||||
2021-12-14 | 2021-12-13 | 4 | Vaddi Krishna | PRLD | Common Stock | D | 12.1294 | 8,000 | 97 | 1,053,519 | ||||
2021-12-01 | 2021-11-29 | 4 | Chardonnet Laurent | PRLD | Employee Stock Option (Right to Buy) | D | 13.75 | 180,000 | 180,000 | |||||
2021-12-01 | 3 | Chardonnet Laurent | PRLD | Common Stock | D | 3,000 | ||||||||
2021-11-18 | 2021-11-16 | 4 | Morosini Deborah | PRLD | Employee Stock Option (right to buy) | D | 12.85 | -28,751 | 196,045 | |||||
2021-11-18 | 2021-11-16 | 4 | Morosini Deborah | PRLD | Common Stock | D | 16.4250 | -400 | -7 | 444 | ||||
2021-11-18 | 2021-11-16 | 4 | Morosini Deborah | PRLD | Common Stock | D | 15.8711 | -28,351 | -450 | 844 | ||||
2021-11-18 | 2021-11-16 | 4 | Morosini Deborah | PRLD | Common Stock | D | 12.8500 | 28,751 | 369 | 29,195 | ||||
2021-10-14 | 2021-10-13 | 4 | Sandor Victor | PRLD | Director Stock Option (Right to Buy) | D | 15.81 | 8,022 | 8,022 | |||||
2021-10-06 | 2021-10-05 | 4 | Mauro David J | PRLD | Employee Stock Option (Right to Buy) | D | 1.89 | -15,000 | 137,610 | |||||
2021-10-06 | 2021-10-05 | 4 | Mauro David J | PRLD | Common Stock | D | 32.0637 | -1,289 | -41 | 0 | ||||
2021-10-06 | 2021-10-05 | 4 | Mauro David J | PRLD | Common Stock | D | 31.3030 | -7,803 | -244 | 1,289 | ||||
2021-10-06 | 2021-10-05 | 4 | Mauro David J | PRLD | Common Stock | D | 30.2577 | -5,908 | -179 | 9,092 | ||||
2021-10-06 | 2021-10-05 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 15,000 | 28 | 15,000 | ||||
2021-09-09 | 2021-09-07 | 4 | Mauro David J | PRLD | Employee Stock Option (Right to Buy) | D | 1.89 | -15,000 | 167,610 | |||||
2021-09-09 | 2021-09-07 | 4 | Mauro David J | PRLD | Common Stock | D | 37.7876 | -4,640 | -175 | 0 | ||||
2021-09-09 | 2021-09-07 | 4 | Mauro David J | PRLD | Common Stock | D | 36.9234 | -2,873 | -106 | 4,640 | ||||
2021-09-09 | 2021-09-07 | 4 | Mauro David J | PRLD | Common Stock | D | 35.9112 | -7,487 | -269 | 7,513 | ||||
2021-09-09 | 2021-09-07 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 15,000 | 28 | 15,000 | ||||
2021-09-07 | 2021-09-02 | 4 | Pierce Christopher | PRLD | Employee Stock Option (right to buy) | D | 12.85 | -17,000 | 207,796 | |||||
2021-09-07 | 2021-09-02 | 4 | Pierce Christopher | PRLD | Common Stock | D | 42.4974 | -6,930 | -295 | 3,750 | ||||
2021-09-07 | 2021-09-02 | 4 | Pierce Christopher | PRLD | Common Stock | D | 41.5176 | -6,727 | -279 | 10,680 | ||||
2021-09-07 | 2021-09-02 | 4 | Pierce Christopher | PRLD | Common Stock | D | 40.2922 | -3,343 | -135 | 17,407 | ||||
2021-09-07 | 2021-09-02 | 4 | Pierce Christopher | PRLD | Common Stock | D | 12.8500 | 17,000 | 218 | 20,750 | ||||
2021-08-30 | 2021-08-27 | 4 | Scherle Peggy | PRLD | Employee Stock Option (Right to Buy) | D | 1.43 | -6,014 | 27,018 | |||||
2021-08-30 | 2021-08-27 | 4 | Scherle Peggy | PRLD | Common Stock | D | 37.0761 | -607 | -23 | 172,920 | ||||
2021-08-30 | 2021-08-27 | 4 | Scherle Peggy | PRLD | Common Stock | D | 36.2340 | -2,707 | -98 | 173,527 | ||||
2021-08-30 | 2021-08-27 | 4 | Scherle Peggy | PRLD | Common Stock | D | 35.3247 | -2,700 | -95 | 176,234 | ||||
2021-08-30 | 2021-08-27 | 4 | Scherle Peggy | PRLD | Common Stock | D | 1.4300 | 6,014 | 9 | 178,934 | ||||
2021-08-30 | 2021-08-26 | 4 | Scherle Peggy | PRLD | Employee Stock Option (Right to Buy) | D | 1.43 | -1,700 | 33,032 | |||||
2021-08-30 | 2021-08-26 | 4 | Scherle Peggy | PRLD | Common Stock | D | 35.1879 | -1,700 | -60 | 172,920 | ||||
2021-08-30 | 2021-08-26 | 4 | Scherle Peggy | PRLD | Common Stock | D | 1.4300 | 1,700 | 2 | 174,620 | ||||
2021-08-27 | 2021-08-25 | 4 | Piper Brian | PRLD | Employee Stock Option (Right to Buy) | D | 1.89 | -8,333 | 264,329 | |||||
2021-08-27 | 2021-08-25 | 4 | Piper Brian | PRLD | Common Stock | D | 34.3299 | -2,344 | -80 | 0 | ||||
2021-08-27 | 2021-08-25 | 4 | Piper Brian | PRLD | Common Stock | D | 33.2308 | -3,889 | -129 | 2,344 | ||||
2021-08-27 | 2021-08-25 | 4 | Piper Brian | PRLD | Common Stock | D | 32.4398 | -2,100 | -68 | 6,233 | ||||
2021-08-27 | 2021-08-25 | 4 | Piper Brian | PRLD | Common Stock | D | 1.8900 | 8,333 | 16 | 8,333 | ||||
2021-08-17 | 2021-08-13 | 4 | Scherle Peggy | PRLD | Employee Stock Option (Right to Buy) | D | 1.43 | -1,728 | 34,732 | |||||
2021-08-17 | 2021-08-13 | 4 | Scherle Peggy | PRLD | Employee Stock Option (Right to Buy) | D | 1.89 | -558 | 42,672 | |||||
2021-08-17 | 2021-08-13 | 4 | Scherle Peggy | PRLD | Common Stock | D | 35.0662 | -2,286 | -80 | 172,920 | ||||
2021-08-17 | 2021-08-13 | 4 | Scherle Peggy | PRLD | Common Stock | D | 1.4300 | 1,728 | 2 | 175,206 | ||||
2021-08-17 | 2021-08-13 | 4 | Scherle Peggy | PRLD | Common Stock | D | 1.8900 | 558 | 1 | 173,478 | ||||
2021-08-09 | 2021-08-05 | 4 | Mauro David J | PRLD | Employee Stock Option (Right to Buy) | D | 1.89 | -15,000 | 167,610 | |||||
2021-08-09 | 2021-08-05 | 4 | Mauro David J | PRLD | Common Stock | D | 32.6300 | -100 | -3 | 0 | ||||
2021-08-09 | 2021-08-05 | 4 | Mauro David J | PRLD | Common Stock | D | 32.1457 | -6,721 | -216 | 100 | ||||
2021-08-09 | 2021-08-05 | 4 | Mauro David J | PRLD | Common Stock | D | 31.0278 | -2,063 | -64 | 6,821 | ||||
2021-08-09 | 2021-08-05 | 4 | Mauro David J | PRLD | Common Stock | D | 29.9329 | -6,116 | -183 | 8,884 | ||||
2021-08-09 | 2021-08-05 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 15,000 | 28 | 15,000 | ||||
2021-07-29 | 2021-07-27 | 4 | Scherle Peggy | PRLD | Employee Stock Option (Right to Buy) | D | 1.43 | -20,000 | 36,460 | |||||
2021-07-29 | 2021-07-27 | 4 | Scherle Peggy | PRLD | Common Stock | D | 36.0882 | -680 | -25 | 172,920 | ||||
2021-07-29 | 2021-07-27 | 4 | Scherle Peggy | PRLD | Common Stock | D | 35.4472 | -19,320 | -685 | 173,600 | ||||
2021-07-29 | 2021-07-27 | 4 | Scherle Peggy | PRLD | Common Stock | D | 1.4300 | 20,000 | 29 | 192,920 | ||||
2021-07-22 | 2021-07-20 | 4 | Scherle Peggy | PRLD | Employee Stock Option (Right to Buy) | D | 31.23 | 95,000 | 95,000 | |||||
2021-07-22 | 2021-07-20 | 4 | Vaddi Krishna | PRLD | Employee Stock Option (Right to Buy) | D | 31.23 | 285,800 | 285,800 | |||||
2021-07-22 | 2021-07-20 | 4 | Morosini Deborah | PRLD | Employee Stock Option (Right to Buy) | D | 31.23 | 85,000 | 85,000 | |||||
2021-07-22 | 2021-07-20 | 4 | Mauro David J | PRLD | Employee Stock Option (Right to Buy) | D | 31.23 | 95,000 | 95,000 | |||||
2021-07-22 | 2021-07-20 | 4 | Pierce Christopher | PRLD | Employee Stock Option (Right to Buy) | D | 31.23 | 85,000 | 85,000 | |||||
2021-07-22 | 2021-07-20 | 4 | Piper Brian | PRLD | Employee Stock Option (Right to Buy) | D | 31.23 | 115,650 | 115,650 | |||||
2021-07-22 | 2021-07-20 | 4 | Combs Andrew | PRLD | Employee Stock Option (Right to Buy) | D | 31.23 | 95,000 | 95,000 | |||||
2021-07-20 | 2021-07-19 | 4 | Babler Martin | PRLD | Employee Stock Option (Right to Buy) | D | 31.37 | 36,400 | 36,400 | |||||
2021-07-08 | 2021-07-06 | 4 | Mauro David J | PRLD | Employee Stock Option (Right to Buy) | D | 1.89 | -15,000 | 182,610 | |||||
2021-07-08 | 2021-07-06 | 4 | Mauro David J | PRLD | Common Stock | D | 28.8433 | -300 | -9 | 0 | ||||
2021-07-08 | 2021-07-06 | 4 | Mauro David J | PRLD | Common Stock | D | 28.1343 | -4,255 | -120 | 300 | ||||
2021-07-08 | 2021-07-06 | 4 | Mauro David J | PRLD | Common Stock | D | 27.1654 | -10,445 | -284 | 4,555 | ||||
2021-07-08 | 2021-07-06 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 15,000 | 28 | 15,000 | ||||
2021-06-22 | 2021-06-18 | 4 | Sandor Victor | PRLD | Director Stock Option (Right to Buy) | D | 31.02 | 23,344 | 23,344 | |||||
2021-06-22 | 2021-06-18 | 4 | FRIEDMAN PAUL A | PRLD | Director Stock Option (Right to Buy) | D | 31.02 | 23,344 | 23,344 | |||||
2021-06-22 | 2021-06-18 | 4 | Dier Mardi | PRLD | Director Stock Option (Right to Buy) | D | 31.02 | 23,344 | 23,344 | |||||
2021-06-22 | 2021-06-18 | 4 | Bonita David P | PRLD | Director Stock Option (Right to Buy) | D | 31.02 | 23,344 | 23,344 | |||||
2021-06-22 | 2021-06-18 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Qualified Stock Options (right to buy) | I | 31.02 | 23,344 | 23,344 | |||||
2021-06-09 | 2021-06-07 | 4 | Mauro David J | PRLD | Common Stock | D | 1.89 | -15,000 | 197,610 | |||||
2021-06-09 | 2021-06-07 | 4 | Mauro David J | PRLD | Common Stock | D | 32.7295 | -12,700 | -416 | 0 | ||||
2021-06-09 | 2021-06-07 | 4 | Mauro David J | PRLD | Common Stock | D | 31.6244 | -900 | -28 | 12,700 | ||||
2021-06-09 | 2021-06-07 | 4 | Mauro David J | PRLD | Common Stock | D | 30.3541 | -1,400 | -42 | 13,600 | ||||
2021-06-09 | 2021-06-07 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 15,000 | 28 | 15,000 | ||||
2021-05-27 | 2021-05-25 | 4 | Piper Brian | PRLD | Employee Stock Option (Right to Buy) | D | 1.89 | -8,333 | 272,662 | |||||
2021-05-27 | 2021-05-25 | 4 | Piper Brian | PRLD | Common Stock | D | 36.0930 | -399 | -14 | 0 | ||||
2021-05-27 | 2021-05-25 | 4 | Piper Brian | PRLD | Common Stock | D | 35.4469 | -1,736 | -62 | 399 | ||||
2021-05-27 | 2021-05-25 | 4 | Piper Brian | PRLD | Common Stock | D | 34.1119 | -3,088 | -105 | 2,135 | ||||
2021-05-27 | 2021-05-25 | 4 | Piper Brian | PRLD | Common Stock | D | 33.5250 | -3,110 | -104 | 5,223 | ||||
2021-05-27 | 2021-05-25 | 4 | Piper Brian | PRLD | Common Stock | D | 1.8900 | 8,333 | 16 | 8,333 | ||||
2021-05-11 | 2021-05-07 | 4 | Scherle Peggy | PRLD | Employee Stock Option (right to buy) | D | 1.43 | -10,000 | 56,460 | |||||
2021-05-11 | 2021-05-07 | 4 | Scherle Peggy | PRLD | Common Stock | D | 41.8500 | -200 | -8 | 172,920 | ||||
2021-05-11 | 2021-05-07 | 4 | Scherle Peggy | PRLD | Common Stock | D | 41.1395 | -5,836 | -240 | 173,120 | ||||
2021-05-11 | 2021-05-07 | 4 | Scherle Peggy | PRLD | Common Stock | D | 40.2957 | -3,964 | -160 | 178,956 | ||||
2021-05-11 | 2021-05-07 | 4 | Scherle Peggy | PRLD | Common Stock | D | 1.4300 | 10,000 | 14 | 182,920 | ||||
2021-05-10 | 2021-05-05 | 4 | Mauro David J | PRLD | Common Stock | D | 1.89 | -15,000 | 212,610 | |||||
2021-05-10 | 2021-05-05 | 4 | Mauro David J | PRLD | Common Stock | D | 41.0682 | -1,109 | -46 | 0 | ||||
2021-05-10 | 2021-05-05 | 4 | Mauro David J | PRLD | Common Stock | D | 40.2967 | -10,476 | -422 | 1,109 | ||||
2021-05-10 | 2021-05-05 | 4 | Mauro David J | PRLD | Common Stock | D | 39.3555 | -3,415 | -134 | 11,585 | ||||
2021-05-10 | 2021-05-05 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 15,000 | 28 | 15,000 | ||||
2021-04-30 | 2021-04-29 | 4 | Pierce Christopher | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -3,295 | 4,323 | |||||
2021-04-30 | 2021-04-29 | 4 | Pierce Christopher | PRLD | Common Stock | D | 40.2928 | -3,295 | -133 | 3,750 | ||||
2021-04-30 | 2021-04-29 | 4 | Pierce Christopher | PRLD | Common Stock | D | 1.8900 | 3,295 | 6 | 7,045 | ||||
2021-04-30 | 2021-04-29 | 4 | Morosini Deborah | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -3,223 | 4,323 | |||||
2021-04-30 | 2021-04-29 | 4 | Morosini Deborah | PRLD | Common Stock | D | 40.2896 | -3,223 | -130 | 444 | ||||
2021-04-30 | 2021-04-29 | 4 | Morosini Deborah | PRLD | Common Stock | D | 1.8900 | 3,223 | 6 | 3,667 | ||||
2021-04-29 | 2021-04-27 | 4 | Mauro David J | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -25,000 | 227,610 | |||||
2021-04-29 | 2021-04-27 | 4 | Mauro David J | PRLD | Common Stock | D | 36.1137 | -1,711 | -62 | 0 | ||||
2021-04-29 | 2021-04-27 | 4 | Mauro David J | PRLD | Common Stock | D | 35.6759 | -15,601 | -557 | 1,711 | ||||
2021-04-29 | 2021-04-27 | 4 | Mauro David J | PRLD | Common Stock | D | 34.6615 | -7,688 | -266 | 17,312 | ||||
2021-04-29 | 2021-04-27 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 25,000 | 47 | 25,000 | ||||
2021-04-21 | 2021-04-19 | 4 | Mauro David J | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -25,000 | 252,610 | |||||
2021-04-21 | 2021-04-19 | 4 | Mauro David J | PRLD | Common Stock | D | 31.2692 | -4,000 | -125 | 0 | ||||
2021-04-21 | 2021-04-19 | 4 | Mauro David J | PRLD | Common Stock | D | 30.8225 | -21,000 | -647 | 4,000 | ||||
2021-04-21 | 2021-04-19 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 25,000 | 47 | 25,000 | ||||
2021-04-15 | 2021-04-08 | 4 | Scherle Peggy | PRLD | Employee Stock Option (right to buy) | D | 1.43 | -4,630 | 66,460 | |||||
2021-04-15 | 2021-04-08 | 4 | Scherle Peggy | PRLD | Common Stock | D | 39.5688 | -1,669 | -66 | 172,920 | ||||
2021-04-15 | 2021-04-08 | 4 | Scherle Peggy | PRLD | Common Stock | D | 38.9726 | -669 | -26 | 174,589 | ||||
2021-04-15 | 2021-04-08 | 4 | Scherle Peggy | PRLD | Common Stock | D | 37.7182 | -875 | -33 | 175,258 | ||||
2021-04-15 | 2021-04-08 | 4 | Scherle Peggy | PRLD | Common Stock | D | 36.9707 | -1,417 | -52 | 176,133 | ||||
2021-04-15 | 2021-04-08 | 4 | Scherle Peggy | PRLD | Common Stock | D | 1.4300 | 4,630 | 7 | 177,550 | ||||
2021-04-15 | 2021-04-08 | 4 | Pierce Christopher | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -200 | 7,618 | |||||
2021-04-15 | 2021-04-08 | 4 | Pierce Christopher | PRLD | Common Stock | D | 40.0000 | -200 | -8 | 3,750 | ||||
2021-04-15 | 2021-04-08 | 4 | Pierce Christopher | PRLD | Common Stock | D | 1.8900 | 200 | 0 | 3,950 | ||||
2021-04-15 | 2021-04-08 | 4 | Morosini Deborah | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -100 | 7,546 | |||||
2021-04-15 | 2021-04-08 | 4 | Morosini Deborah | PRLD | Common Stock | D | 40.0000 | -100 | -4 | 444 | ||||
2021-04-15 | 2021-04-08 | 4 | Morosini Deborah | PRLD | Common Stock | D | 1.8900 | 100 | 0 | 544 | ||||
2021-04-15 | 2021-04-08 | 4 | Mauro David J | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -9,617 | 277,610 | |||||
2021-04-15 | 2021-04-08 | 4 | Mauro David J | PRLD | Common Stock | D | 39.5584 | -3,549 | -140 | 0 | ||||
2021-04-15 | 2021-04-08 | 4 | Mauro David J | PRLD | Common Stock | D | 38.9972 | -1,293 | -50 | 3,549 | ||||
2021-04-15 | 2021-04-08 | 4 | Mauro David J | PRLD | Common Stock | D | 37.8283 | -1,501 | -57 | 4,842 | ||||
2021-04-15 | 2021-04-08 | 4 | Mauro David J | PRLD | Common Stock | D | 37.0360 | -3,274 | -121 | 6,343 | ||||
2021-04-15 | 2021-04-08 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 9,617 | 18 | 9,617 | ||||
2021-04-09 | 2021-04-07 | 4 | Scherle Peggy | PRLD | Employee Stock Option (right to buy) | D | 1.43 | -15,370 | 71,090 | |||||
2021-04-09 | 2021-04-07 | 4 | Scherle Peggy | PRLD | Common Stock | D | 40.3000 | -200 | -8 | 172,920 | ||||
2021-04-09 | 2021-04-07 | 4 | Scherle Peggy | PRLD | Common Stock | D | 39.6278 | -6,881 | -273 | 173,120 | ||||
2021-04-09 | 2021-04-07 | 4 | Scherle Peggy | PRLD | Common Stock | D | 39.0162 | -8,289 | -323 | 180,001 | ||||
2021-04-09 | 2021-04-07 | 4 | Scherle Peggy | PRLD | Common Stock | D | 1.4300 | 15,370 | 22 | 188,290 | ||||
2021-04-09 | 2021-04-07 | 4 | Pierce Christopher | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -828 | 7,818 | |||||
2021-04-09 | 2021-04-07 | 4 | Pierce Christopher | PRLD | Common Stock | D | 40.0826 | -828 | -33 | 3,750 | ||||
2021-04-09 | 2021-04-07 | 4 | Pierce Christopher | PRLD | Common Stock | D | 1.8900 | 828 | 2 | 4,578 | ||||
2021-04-09 | 2021-04-07 | 4 | Morosini Deborah | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -1,000 | 7,646 | |||||
2021-04-09 | 2021-04-07 | 4 | Morosini Deborah | PRLD | Common Stock | D | 40.0430 | -1,000 | -40 | 444 | ||||
2021-04-09 | 2021-04-07 | 4 | Morosini Deborah | PRLD | Common Stock | D | 1.8900 | 1,000 | 2 | 1,444 | ||||
2021-04-09 | 2021-04-07 | 4 | Mauro David J | PRLD | Employee Stock Option (right to buy) | D | 1.89 | -15,383 | 287,227 | |||||
2021-04-09 | 2021-04-07 | 4 | Mauro David J | PRLD | Common Stock | D | 39.6888 | -7,083 | -281 | 0 | ||||
2021-04-09 | 2021-04-07 | 4 | Mauro David J | PRLD | Common Stock | D | 39.0250 | -8,300 | -324 | 7,083 | ||||
2021-04-09 | 2021-04-07 | 4 | Mauro David J | PRLD | Common Stock | D | 1.8900 | 15,383 | 29 | 15,383 | ||||
2021-01-29 | 2021-01-27 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Qualified Stock Options (right to buy) | I | 12.85 | -5,188 | 41,500 | |||||
2021-01-29 | 2021-01-27 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Qualified Stock Options (right to buy) | I | 12.85 | -5,188 | 41,500 | |||||
2021-01-29 | 2021-01-27 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 12.8500 | 5,188 | 67 | 9,252,951 | ||||
2021-01-29 | 2021-01-27 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 12.8500 | 5,188 | 67 | 9,252,951 | ||||
2021-01-13 | 2021-01-11 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Voting Common Stock | I | 60.0000 | 154,222 | 9,253 | 5,212,371 | ||||
2021-01-13 | 2021-01-11 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Voting Common Stock | I | 60.0000 | 12,444 | 747 | 509,480 | ||||
2021-01-12 | 2021-01-11 | 4 | ORBIMED ADVISORS LLC See Footnotes | PRLD | Non-Voting Common Stock | I | 60.0000 | 41,700 | 2,502 | 5,596,886 | ||||
2021-01-12 | 2021-01-11 | 4 | Bonita David P See Footnotes | PRLD | Non-Voting Common Stock | I | 60.0000 | 41,700 | 2,502 | 5,596,886 | ||||
2020-09-30 | 2020-08-21 | 4/A | ORBIMED ADVISORS LLC | PRLD | Series C Preferred Stock | I | 1,033,084 | 1,033,084 | ||||||
2020-09-30 | 2020-03-27 | 4/A | ORBIMED ADVISORS LLC | PRLD | Series B Preferred Stock | I | 3,681,822 | 7,363,644 | ||||||
2020-09-30 | 2020-09-29 | 4 | FRIEDMAN PAUL A | PRLD | Series B Preferred Stock | D | -152,576 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | FRIEDMAN PAUL A | PRLD | Series A Preferred Stock | D | -295,794 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | FRIEDMAN PAUL A | PRLD | Common Stock | D | 152,576 | 500,098 | ||||||
2020-09-30 | 2020-09-29 | 4 | FRIEDMAN PAUL A | PRLD | Common Stock | D | 295,794 | 347,522 | ||||||
2020-09-30 | 2020-03-27 | 4 | FRIEDMAN PAUL A | PRLD | Series B Preferred Stock | D | 76,288 | 152,576 | ||||||
2020-09-30 | 2020-09-29 | 4 | Bonita David P | PRLD | Non-Voting Common Stock | I | 5,555,186 | 5,555,186 | ||||||
2020-09-30 | 2020-09-29 | 4 | Bonita David P | PRLD | Series C Preferred Stock | I | -413,234 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | Bonita David P | PRLD | Series C Preferred Stock | I | -619,850 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | Bonita David P | PRLD | Series B Preferred Stock | I | -2,945,458 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | Bonita David P | PRLD | Series B Preferred Stock | I | -4,418,186 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | Bonita David P | PRLD | Series A Preferred Stock | I | -2,196,494 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | Bonita David P | PRLD | Series A Preferred Stock | I | -3,294,743 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | Bonita David P | PRLD | Common Stock | I | 8,332,779 | 9,250,191 | ||||||
2020-09-30 | 2020-09-25 | 4 | Bonita David P | PRLD | Common Stock | I | 19.0000 | 710,500 | 13,500 | 917,412 | ||||
2020-09-30 | 2020-09-25 | 4 | Bonita David P | PRLD | Common Stock | I | 19.0000 | 526,300 | 10,000 | 526,300 | ||||
2020-09-30 | 2020-09-24 | 4 | Bonita David P | PRLD | Director Stock Option (right to buy) | D | 12.85 | 46,688 | 46,688 | |||||
2020-09-30 | 2020-08-21 | 4 | Bonita David P | PRLD | Series C Preferred Stock | I | 1,033,084 | 1,033,084 | ||||||
2020-09-30 | 2020-03-27 | 4 | Bonita David P | PRLD | Series B Preferred Stock | I | 3,681,822 | 7,363,644 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Voting Common Stock | I | 382,884 | 5,058,149 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series C Convertible Preferred Stock | I | -382,884 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Voting Common Stock | I | 30,349 | 497,036 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series C Convertible Preferred Stock | I | -30,349 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series C Convertible Preferred Stock | I | -574,327 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series C Convertible Preferred Stock | I | -45,524 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Voting Common Stock | I | 2,698,424 | 4,675,265 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series B Convertible Preferred Stock | I | -2,698,424 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Voting Common Stock | I | 247,034 | 466,687 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series B Convertible Preferred Stock | I | -247,034 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series B Convertible Preferred Stock | I | -4,047,634 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series B Convertible Preferred Stock | I | -370,552 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Voting Common Stock | I | 1,976,841 | 1,976,841 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series A Convertible Preferred Stock | I | -1,976,841 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Voting Common Stock | I | 219,653 | 219,653 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series A Convertible Preferred Stock | I | -219,653 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series A Convertible Preferred Stock | I | -2,965,263 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series A Convertible Preferred Stock | I | -329,478 | 0 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 19.0000 | 1,474,319 | 28,012 | 9,247,763 | ||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 19.0000 | 104,628 | 1,988 | 870,873 | ||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 574,327 | 7,773,444 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 45,524 | 766,245 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 4,047,634 | 7,199,117 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 370,552 | 720,721 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 2,965,263 | 3,151,483 | ||||||
2020-09-30 | 2020-09-29 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Common Stock | I | 329,478 | 350,169 | ||||||
2020-09-30 | 2020-09-24 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Non-Qualified Stock Option (right to buy) | I | 12.85 | 46,688 | 46,688 | |||||
2020-09-30 | 2020-08-21 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series C Preferred Stock | I | 14.5196 | 957,211 | 13,898 | 957,211 | ||||
2020-09-30 | 2020-08-21 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series C Preferred Stock | I | 14.5196 | 75,873 | 1,102 | 75,873 | ||||
2020-09-30 | 2020-03-27 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series B Preferred Stock | I | 3.9324 | 3,373,029 | 13,264 | 3,373,029 | ||||
2020-09-30 | 2020-03-27 | 4 | BAKER BROS. ADVISORS LP See Footnotes | PRLD | Series B Preferred Stock | I | 3.9324 | 308,793 | 1,214 | 308,793 | ||||
2020-09-29 | 2020-09-29 | 4 | Combs Andrew | PRLD | Common Stock | D | 19.0000 | 1,000 | 19 | 260,380 | ||||
2020-09-29 | 2020-09-29 | 4 | Vaddi Krishna By Trust | PRLD | Series A Preferred Stock | I | -32,876 | 0 | ||||||
2020-09-29 | 2020-09-29 | 4 | Vaddi Krishna By Trust | PRLD | Series A Preferred Stock | I | -32,876 | 0 | ||||||
2020-09-29 | 2020-09-29 | 4 | Vaddi Krishna | PRLD | Series A Preferred Stock | I | -101,477 | 0 | ||||||
2020-09-29 | 2020-09-29 | 4 | Vaddi Krishna By Trust | PRLD | Common Stock | I | 32,876 | 551,774 | ||||||
2020-09-29 | 2020-09-29 | 4 | Vaddi Krishna By Trust | PRLD | Common Stock | I | 32,876 | 551,774 | ||||||
2020-09-29 | 2020-09-29 | 4 | Vaddi Krishna | PRLD | Common Stock | I | 101,477 | 101,477 | ||||||
2020-09-29 | 2020-09-29 | 4 | Pierce Christopher | PRLD | Common Stock | D | 19.0000 | 3,750 | 71 | 3,750 | ||||
2020-09-29 | 2020-09-29 | 4 | Morosini Deborah | PRLD | Common Stock | D | 19.0000 | 444 | 8 | 444 | ||||
2020-09-29 | 2020-09-29 | 4 | Dier Mardi | PRLD | Common Stock | D | 19.0000 | 10,000 | 190 | 10,000 | ||||
2020-09-29 | 2020-09-29 | 4 | ORBIMED ADVISORS LLC | PRLD | Non-Voting Common Stock | I | 5,555,186 | 5,555,186 | ||||||
2020-09-29 | 2020-09-29 | 4 | ORBIMED ADVISORS LLC | PRLD | Series C Preferred Stock | I | -413,234 | 0 | ||||||
2020-09-29 | 2020-09-29 | 4 | ORBIMED ADVISORS LLC | PRLD | Series C Preferred Stock | I | -619,850 | 0 | ||||||
2020-09-29 | 2020-09-29 | 4 | ORBIMED ADVISORS LLC | PRLD | Series B Preferred Stock | I | -2,945,458 | 0 | ||||||
2020-09-29 | 2020-09-29 | 4 | ORBIMED ADVISORS LLC | PRLD | Series B Preferred Stock | I | -4,418,186 | 0 | ||||||
2020-09-29 | 2020-09-29 | 4 | ORBIMED ADVISORS LLC | PRLD | Series A Prefered Stock | I | -2,196,494 | 0 | ||||||
2020-09-29 | 2020-09-29 | 4 | ORBIMED ADVISORS LLC | PRLD | Series A Preferred Stock | I | -3,294,743 | 0 | ||||||
2020-09-29 | 2020-09-29 | 4 | ORBIMED ADVISORS LLC | PRLD | Common Stock | I | 8,332,779 | 9,250,191 | ||||||
2020-09-29 | 2020-09-25 | 4 | ORBIMED ADVISORS LLC | PRLD | Common Stock | I | 19.0000 | 710,500 | 13,500 | 917,412 | ||||
2020-09-29 | 2020-09-25 | 4 | ORBIMED ADVISORS LLC | PRLD | Common Stock | I | 19.0000 | 526,300 | 10,000 | 526,300 | ||||
2020-09-28 | 2020-09-24 | 4 | Sandor Victor | PRLD | Director Stock Option (right to buy) | D | 19.00 | 3,458 | 3,458 | |||||
2020-09-28 | 2020-09-24 | 4 | Dier Mardi | PRLD | Director Stock Option (right to buy) | D | 19.00 | 3,458 | 3,458 | |||||
2020-09-24 | 3 | Scherle Peggy | PRLD | Common Stock | D | 172,920 | ||||||||
2020-09-24 | 3 | BAKER JULIAN | PRLD | Common Stock | I | 186,220 | ||||||||
2020-09-24 | 3 | BAKER JULIAN | PRLD | Common Stock | I | 20,691 | ||||||||
2020-09-24 | 3 | Vaddi Krishna By Trust | PRLD | Common Stock | I | 423,655 | ||||||||
2020-09-24 | 3 | Vaddi Krishna | PRLD | Common Stock | D | 1,045,519 | ||||||||
2020-09-24 | 3 | Vaddi Krishna By Trust | PRLD | Common Stock | I | 518,898 | ||||||||
2020-09-24 | 3 | Vaddi Krishna By Trust | PRLD | Common Stock | I | 518,900 | ||||||||
2020-09-24 | 3 | OrbiMed Capital GP VI LLC | PRLD | Common Stock | I | 206,912 | ||||||||
2020-09-24 | 3 | FRIEDMAN PAUL A | PRLD | Common Stock | D | 51,728 | ||||||||
2020-09-24 | 3 | Combs Andrew | PRLD | Common Stock | D | 259,380 | ||||||||
2020-09-24 | 3 | Bonita David P See footnotes | PRLD | Common Stock | I | 206,912 |